$20.91
$-0.32 (-1.51%)
End-of-day quote: 05/17/2024
NasdaqGS:EXEL
Exelixis Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | NYSE | Outperform | $131.19 | $130.51 | 0.00% | 11 | $332.28B |
| ROG | Roche Holding | SWX | Hold | CHF237.10 | CHF307.83 | 0.00% | 9 | CHF191.28B |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $982.29 | $961.26 | 0.00% | 8 | $105.97B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.03 | $58.15 | 0.00% | 10 | $89.25B |
| BAYN | Bayer | XTRA | Hold | 28.58€ | 45.15€ | 0.00% | 4 | 28.08€B |
| 4523 | Eisai | TSE | Outperform | ¥6.78k | ¥9.58k | 0.00% | 0 | ¥1.97T |
| INCY | Incyte | NasdaqGS | Outperform | $57.10 | $77.05 | 0.00% | 8 | $12.01B |
| JAZZ | Jazz Pharmaceuticals | NasdaqGS | Outperform | $108.99 | $188.32 | 0.00% | 4 | $7.13B |
| BPMC | Blueprint Medicines | NasdaqGS | Outperform | $104.96 | $85.71 | 0.00% | 5 | $6.78B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $37.31 | $55.60 | 0.00% | 3 | $5.76B |
